MicroRNA‑19a‑3p inhibits the cellular proliferation and invasion of non‑small cell lung cancer by downregulating UBAP2L

MicroRNAs (miRNAs) are increasingly recognized as important regulators of non-small cell lung cancer (NSCLC) progression by directly regulating their target genes. The aim of the present study was to assess the biological role of miR-19a-3p in NSCLC. It was revealed that miR-19a-3p expression was si...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental and therapeutic medicine 2020-09, Vol.20 (3), p.2252-2261
Hauptverfasser: Pan, Yuejiang, Jin, Ke, Xie, Xuan, Wang, Kexi, Zhang, Huizhong
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2261
container_issue 3
container_start_page 2252
container_title Experimental and therapeutic medicine
container_volume 20
creator Pan, Yuejiang
Jin, Ke
Xie, Xuan
Wang, Kexi
Zhang, Huizhong
description MicroRNAs (miRNAs) are increasingly recognized as important regulators of non-small cell lung cancer (NSCLC) progression by directly regulating their target genes. The aim of the present study was to assess the biological role of miR-19a-3p in NSCLC. It was revealed that miR-19a-3p expression was significantly downregulated in human NSCLC tissues and cell lines compared with normal tissues and lung epithelial cells. In addition, a lower miR-19a-3p expression was significantly associated with Tumor Node Metastasis stage and lymph node metastasis. Furthermore, the upregulation of miR-19a-3p in NSCLC cell lines significantly inhibited cell proliferation, migration and invasion, as determined using an MTT, colony formation, wound healing and transwell Matrigel invasion assays, respectively. A luciferase reporter assay and western blotting determined that ubiquitin associated protein 2 like (UBAP2L) was a direct target of miR-19a-3p and could be inhibited through the upregulation of miR-19a-3p in NSCLC. In addition, UBAP2L silencing induced similar effects to those observed following miR-19a-3p overexpression. The overexpression of UBAP2L partially reversed the effects of miR-19a-3p on NSCLC cell lines. Collectively, these data indicated that miR-19a-3p may serve as a tumor suppressor partly through the regulation of UBAP2L expression in NSCLC and that the targeting of miR-19a-3p may be a novel method for NSCLC treatment.
doi_str_mv 10.3892/etm.2020.8926
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7401917</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A635435151</galeid><sourcerecordid>A635435151</sourcerecordid><originalsourceid>FETCH-LOGICAL-c389t-762dacce925758e55601fbf227f78924db9ebf95e5f4fa7a929429a5049657d83</originalsourceid><addsrcrecordid>eNptUsuOFCEUrRiNMxln6Z7EjZtugSqKYmPSTnwl7SPGWROKunQzoaCFqjGzMPEX_EW_xFtORzNGSIDLPeeQE05VPWZ0XXeKP4NpXHPK6RqL9l51yqTiK0aZuH88U9Wxk-q8lCuKQ7Ss68TD6qTmshWS8tPq2ztvc_r0fvPz-w-mDK71gfi4972fCpn2QCyEMAeTySGn4B1kM_kUiYkD4q5NWYrkSEwRyWU0IfymkDDHHbEmWsikvyFD-hoz7FBp8ti4fLH5yLePqgfOhALnx_2sunz18vPFm9X2w-u3F5vtyqLNaSVbPhhrQXEhRQdCtJS53nEunUTnzdAr6J0SIFzjjDSKq4YrI2ij0ObQ1WfV81vdw9yPMFiIUzZBH7IfTb7RyXh9txP9Xu_StZYNZYpJFHh6FMjpywxl0qMvi00TIc1F86ZmHad10yD0yT_QqzTniPYWlKgFo4L_Re1MAO2jS_iuXUT1pq0FAplgiFr_B4VzgNHbFMF5vL9DWN0S8FNLyeD-eGRUL5HRGBm9REYvkal_AX2itKE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2435351052</pqid></control><display><type>article</type><title>MicroRNA‑19a‑3p inhibits the cellular proliferation and invasion of non‑small cell lung cancer by downregulating UBAP2L</title><source>PubMed Central</source><creator>Pan, Yuejiang ; Jin, Ke ; Xie, Xuan ; Wang, Kexi ; Zhang, Huizhong</creator><creatorcontrib>Pan, Yuejiang ; Jin, Ke ; Xie, Xuan ; Wang, Kexi ; Zhang, Huizhong</creatorcontrib><description>MicroRNAs (miRNAs) are increasingly recognized as important regulators of non-small cell lung cancer (NSCLC) progression by directly regulating their target genes. The aim of the present study was to assess the biological role of miR-19a-3p in NSCLC. It was revealed that miR-19a-3p expression was significantly downregulated in human NSCLC tissues and cell lines compared with normal tissues and lung epithelial cells. In addition, a lower miR-19a-3p expression was significantly associated with Tumor Node Metastasis stage and lymph node metastasis. Furthermore, the upregulation of miR-19a-3p in NSCLC cell lines significantly inhibited cell proliferation, migration and invasion, as determined using an MTT, colony formation, wound healing and transwell Matrigel invasion assays, respectively. A luciferase reporter assay and western blotting determined that ubiquitin associated protein 2 like (UBAP2L) was a direct target of miR-19a-3p and could be inhibited through the upregulation of miR-19a-3p in NSCLC. In addition, UBAP2L silencing induced similar effects to those observed following miR-19a-3p overexpression. The overexpression of UBAP2L partially reversed the effects of miR-19a-3p on NSCLC cell lines. Collectively, these data indicated that miR-19a-3p may serve as a tumor suppressor partly through the regulation of UBAP2L expression in NSCLC and that the targeting of miR-19a-3p may be a novel method for NSCLC treatment.</description><identifier>ISSN: 1792-0981</identifier><identifier>EISSN: 1792-1015</identifier><identifier>DOI: 10.3892/etm.2020.8926</identifier><identifier>PMID: 32765702</identifier><language>eng</language><publisher>Athens: Spandidos Publications</publisher><subject>Apoptosis ; Breast cancer ; Cancer metastasis ; Cancer therapies ; Cell adhesion &amp; migration ; Cell growth ; Chemotherapy ; Comparative analysis ; Development and progression ; Gene expression ; Kinases ; Liver cancer ; Lung cancer ; Lymphoma ; MicroRNA ; MicroRNAs ; Non-small cell lung cancer ; Phase transitions ; Prostate cancer ; Radiation therapy ; Small cell lung cancer ; Surgery ; Wound healing</subject><ispartof>Experimental and therapeutic medicine, 2020-09, Vol.20 (3), p.2252-2261</ispartof><rights>COPYRIGHT 2020 Spandidos Publications</rights><rights>Copyright Spandidos Publications UK Ltd. 2020</rights><rights>Copyright © 2020, Spandidos Publications 2020</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c389t-762dacce925758e55601fbf227f78924db9ebf95e5f4fa7a929429a5049657d83</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401917/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401917/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids></links><search><creatorcontrib>Pan, Yuejiang</creatorcontrib><creatorcontrib>Jin, Ke</creatorcontrib><creatorcontrib>Xie, Xuan</creatorcontrib><creatorcontrib>Wang, Kexi</creatorcontrib><creatorcontrib>Zhang, Huizhong</creatorcontrib><title>MicroRNA‑19a‑3p inhibits the cellular proliferation and invasion of non‑small cell lung cancer by downregulating UBAP2L</title><title>Experimental and therapeutic medicine</title><description>MicroRNAs (miRNAs) are increasingly recognized as important regulators of non-small cell lung cancer (NSCLC) progression by directly regulating their target genes. The aim of the present study was to assess the biological role of miR-19a-3p in NSCLC. It was revealed that miR-19a-3p expression was significantly downregulated in human NSCLC tissues and cell lines compared with normal tissues and lung epithelial cells. In addition, a lower miR-19a-3p expression was significantly associated with Tumor Node Metastasis stage and lymph node metastasis. Furthermore, the upregulation of miR-19a-3p in NSCLC cell lines significantly inhibited cell proliferation, migration and invasion, as determined using an MTT, colony formation, wound healing and transwell Matrigel invasion assays, respectively. A luciferase reporter assay and western blotting determined that ubiquitin associated protein 2 like (UBAP2L) was a direct target of miR-19a-3p and could be inhibited through the upregulation of miR-19a-3p in NSCLC. In addition, UBAP2L silencing induced similar effects to those observed following miR-19a-3p overexpression. The overexpression of UBAP2L partially reversed the effects of miR-19a-3p on NSCLC cell lines. Collectively, these data indicated that miR-19a-3p may serve as a tumor suppressor partly through the regulation of UBAP2L expression in NSCLC and that the targeting of miR-19a-3p may be a novel method for NSCLC treatment.</description><subject>Apoptosis</subject><subject>Breast cancer</subject><subject>Cancer metastasis</subject><subject>Cancer therapies</subject><subject>Cell adhesion &amp; migration</subject><subject>Cell growth</subject><subject>Chemotherapy</subject><subject>Comparative analysis</subject><subject>Development and progression</subject><subject>Gene expression</subject><subject>Kinases</subject><subject>Liver cancer</subject><subject>Lung cancer</subject><subject>Lymphoma</subject><subject>MicroRNA</subject><subject>MicroRNAs</subject><subject>Non-small cell lung cancer</subject><subject>Phase transitions</subject><subject>Prostate cancer</subject><subject>Radiation therapy</subject><subject>Small cell lung cancer</subject><subject>Surgery</subject><subject>Wound healing</subject><issn>1792-0981</issn><issn>1792-1015</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNptUsuOFCEUrRiNMxln6Z7EjZtugSqKYmPSTnwl7SPGWROKunQzoaCFqjGzMPEX_EW_xFtORzNGSIDLPeeQE05VPWZ0XXeKP4NpXHPK6RqL9l51yqTiK0aZuH88U9Wxk-q8lCuKQ7Ss68TD6qTmshWS8tPq2ztvc_r0fvPz-w-mDK71gfi4972fCpn2QCyEMAeTySGn4B1kM_kUiYkD4q5NWYrkSEwRyWU0IfymkDDHHbEmWsikvyFD-hoz7FBp8ti4fLH5yLePqgfOhALnx_2sunz18vPFm9X2w-u3F5vtyqLNaSVbPhhrQXEhRQdCtJS53nEunUTnzdAr6J0SIFzjjDSKq4YrI2ij0ObQ1WfV81vdw9yPMFiIUzZBH7IfTb7RyXh9txP9Xu_StZYNZYpJFHh6FMjpywxl0qMvi00TIc1F86ZmHad10yD0yT_QqzTniPYWlKgFo4L_Re1MAO2jS_iuXUT1pq0FAplgiFr_B4VzgNHbFMF5vL9DWN0S8FNLyeD-eGRUL5HRGBm9REYvkal_AX2itKE</recordid><startdate>20200901</startdate><enddate>20200901</enddate><creator>Pan, Yuejiang</creator><creator>Jin, Ke</creator><creator>Xie, Xuan</creator><creator>Wang, Kexi</creator><creator>Zhang, Huizhong</creator><general>Spandidos Publications</general><general>Spandidos Publications UK Ltd</general><general>D.A. Spandidos</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20200901</creationdate><title>MicroRNA‑19a‑3p inhibits the cellular proliferation and invasion of non‑small cell lung cancer by downregulating UBAP2L</title><author>Pan, Yuejiang ; Jin, Ke ; Xie, Xuan ; Wang, Kexi ; Zhang, Huizhong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c389t-762dacce925758e55601fbf227f78924db9ebf95e5f4fa7a929429a5049657d83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Apoptosis</topic><topic>Breast cancer</topic><topic>Cancer metastasis</topic><topic>Cancer therapies</topic><topic>Cell adhesion &amp; migration</topic><topic>Cell growth</topic><topic>Chemotherapy</topic><topic>Comparative analysis</topic><topic>Development and progression</topic><topic>Gene expression</topic><topic>Kinases</topic><topic>Liver cancer</topic><topic>Lung cancer</topic><topic>Lymphoma</topic><topic>MicroRNA</topic><topic>MicroRNAs</topic><topic>Non-small cell lung cancer</topic><topic>Phase transitions</topic><topic>Prostate cancer</topic><topic>Radiation therapy</topic><topic>Small cell lung cancer</topic><topic>Surgery</topic><topic>Wound healing</topic><toplevel>online_resources</toplevel><creatorcontrib>Pan, Yuejiang</creatorcontrib><creatorcontrib>Jin, Ke</creatorcontrib><creatorcontrib>Xie, Xuan</creatorcontrib><creatorcontrib>Wang, Kexi</creatorcontrib><creatorcontrib>Zhang, Huizhong</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Experimental and therapeutic medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pan, Yuejiang</au><au>Jin, Ke</au><au>Xie, Xuan</au><au>Wang, Kexi</au><au>Zhang, Huizhong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>MicroRNA‑19a‑3p inhibits the cellular proliferation and invasion of non‑small cell lung cancer by downregulating UBAP2L</atitle><jtitle>Experimental and therapeutic medicine</jtitle><date>2020-09-01</date><risdate>2020</risdate><volume>20</volume><issue>3</issue><spage>2252</spage><epage>2261</epage><pages>2252-2261</pages><issn>1792-0981</issn><eissn>1792-1015</eissn><abstract>MicroRNAs (miRNAs) are increasingly recognized as important regulators of non-small cell lung cancer (NSCLC) progression by directly regulating their target genes. The aim of the present study was to assess the biological role of miR-19a-3p in NSCLC. It was revealed that miR-19a-3p expression was significantly downregulated in human NSCLC tissues and cell lines compared with normal tissues and lung epithelial cells. In addition, a lower miR-19a-3p expression was significantly associated with Tumor Node Metastasis stage and lymph node metastasis. Furthermore, the upregulation of miR-19a-3p in NSCLC cell lines significantly inhibited cell proliferation, migration and invasion, as determined using an MTT, colony formation, wound healing and transwell Matrigel invasion assays, respectively. A luciferase reporter assay and western blotting determined that ubiquitin associated protein 2 like (UBAP2L) was a direct target of miR-19a-3p and could be inhibited through the upregulation of miR-19a-3p in NSCLC. In addition, UBAP2L silencing induced similar effects to those observed following miR-19a-3p overexpression. The overexpression of UBAP2L partially reversed the effects of miR-19a-3p on NSCLC cell lines. Collectively, these data indicated that miR-19a-3p may serve as a tumor suppressor partly through the regulation of UBAP2L expression in NSCLC and that the targeting of miR-19a-3p may be a novel method for NSCLC treatment.</abstract><cop>Athens</cop><pub>Spandidos Publications</pub><pmid>32765702</pmid><doi>10.3892/etm.2020.8926</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1792-0981
ispartof Experimental and therapeutic medicine, 2020-09, Vol.20 (3), p.2252-2261
issn 1792-0981
1792-1015
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7401917
source PubMed Central
subjects Apoptosis
Breast cancer
Cancer metastasis
Cancer therapies
Cell adhesion & migration
Cell growth
Chemotherapy
Comparative analysis
Development and progression
Gene expression
Kinases
Liver cancer
Lung cancer
Lymphoma
MicroRNA
MicroRNAs
Non-small cell lung cancer
Phase transitions
Prostate cancer
Radiation therapy
Small cell lung cancer
Surgery
Wound healing
title MicroRNA‑19a‑3p inhibits the cellular proliferation and invasion of non‑small cell lung cancer by downregulating UBAP2L
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T05%3A37%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=MicroRNA%E2%80%9119a%E2%80%913p%20inhibits%20the%20cellular%20proliferation%20and%20invasion%20of%20non%E2%80%91small%20cell%20lung%20cancer%20by%20downregulating%20UBAP2L&rft.jtitle=Experimental%20and%20therapeutic%20medicine&rft.au=Pan,%20Yuejiang&rft.date=2020-09-01&rft.volume=20&rft.issue=3&rft.spage=2252&rft.epage=2261&rft.pages=2252-2261&rft.issn=1792-0981&rft.eissn=1792-1015&rft_id=info:doi/10.3892/etm.2020.8926&rft_dat=%3Cgale_pubme%3EA635435151%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2435351052&rft_id=info:pmid/32765702&rft_galeid=A635435151&rfr_iscdi=true